Advertisement
Coronavirus: EU to get 50 million Pfizer doses early, Johnson & Johnson shot in US limbo
- US weighs next steps for J&J virus shot amid clot mystery
- Several countries battling a worrying spike in Covid-19 cases
Reading Time:3 minutes
Why you can trust SCMP
The European Union said it was expecting 50 million Pfizer coronavirus vaccine doses earlier than expected, as the United States said it would continue a pause in vaccinations using the Johnson & Johnson shot for at least another week so regulators could assess possible blood clot links.
Advertisement
Rival drugmaker AstraZeneca faced a similar setback after Denmark banned its use, also over blood clot links.
Concerns over using the J&J and AstraZeneca vaccines have dampened hopes that mass immunisations would lead to a swift exit from the global pandemic that has killed nearly three million people and ravaged the global economy.
Nevertheless there was some good news as BioNTech/Pfizer announced that 50 million doses that were due to arrive in Europe in late 2021 would instead start arriving as early as this month.
More than 820 million Covid-19 vaccine doses have now been administered globally. Demand continues to outstrip supply, and countries are scrambling to secure the much-needed jabs for their people.
The race to secure vaccines has sparked diplomatic rows, notably between Britain and the EU after the bloc accused London of hoarding jabs. Australia has also accused the EU of falling short on promised doses.
Advertisement